Inhibition of GSK-3β enhances reovirus-induced apoptosis in colon cancer cells

  • Authors:
    • Hye-Jin Min
    • Sang Seok Koh
    • Il-Rae Cho
    • Ratakorn Srisuttee
    • Eun-Hee Park
    • Byung Hak Jhun
    • Yong-Gyun Kim
    • Sangtaek Oh
    • Ju Eun Kwak
    • Randal N. Johnston
    • Young-Hwa Chung
  • View Affiliations

  • Published online on: September 1, 2009     https://doi.org/10.3892/ijo_00000373
  • Pages: 617-624
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Reovirus functions as an oncolytic agent for many types of cancer including colon cancer. Although most studies have emphasized the role of activated Ras signaling in enhancing reoviral oncolysis in susceptible cells, we note that many colon cancers also display elevated β-catenin. Thus, it is possible that enhanced β-catenin may augment reoviral susceptibility in colon cancer cells. To explore this hypothesis, HEK293 cells were treated with the glycogen synthase kinase (GSK)-3β inhibitor LiCl, thereby inducing β-catenin, followed by reoviral infection. Co-administration with LiCl indeed enhanced cell death compared to reovirus infection alone, but this was not associated with elevated reoviral replication. Similarly, HEK293 cells expressing the Frizzled-1 receptor in Wnt3a-conditioned medium also showed reovirus replication equivalent to that in cells in control medium, further suggesting that up-regulation of β-catenin does not enhance the replication of reovirus. Instead, we observed that inhibition of GSK-3β with LiCl decreased reovirus-induced NF-κB activation, leading to accelerated apoptosis via caspase 8 activation. We further found that colon cancer HCT116 cells were sensitized to apoptosis by co-treatment with reovirus and a GSK-3β inhibitor, AR-A014418. Finally, we identified that inhibition of NF-κB sensitized apoptosis of HEK293 or HCT 116 cells during reovirus infection. Taken together, we propose that inhibition of GSK-3β sensitizes reovirus-induced apoptosis of colon cancer cells by down-regulation of NF-κB activity, offering a potentially improved therapeutic strategy for the treatment of colon cancer.

Related Articles

Journal Cover

September 2009
Volume 35 Issue 3

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Min H, Koh SS, Cho I, Srisuttee R, Park E, Jhun BH, Kim Y, Oh S, Kwak JE, Johnston RN, Johnston RN, et al: Inhibition of GSK-3β enhances reovirus-induced apoptosis in colon cancer cells. Int J Oncol 35: 617-624, 2009
APA
Min, H., Koh, S.S., Cho, I., Srisuttee, R., Park, E., Jhun, B.H. ... Chung, Y. (2009). Inhibition of GSK-3β enhances reovirus-induced apoptosis in colon cancer cells. International Journal of Oncology, 35, 617-624. https://doi.org/10.3892/ijo_00000373
MLA
Min, H., Koh, S. S., Cho, I., Srisuttee, R., Park, E., Jhun, B. H., Kim, Y., Oh, S., Kwak, J. E., Johnston, R. N., Chung, Y."Inhibition of GSK-3β enhances reovirus-induced apoptosis in colon cancer cells". International Journal of Oncology 35.3 (2009): 617-624.
Chicago
Min, H., Koh, S. S., Cho, I., Srisuttee, R., Park, E., Jhun, B. H., Kim, Y., Oh, S., Kwak, J. E., Johnston, R. N., Chung, Y."Inhibition of GSK-3β enhances reovirus-induced apoptosis in colon cancer cells". International Journal of Oncology 35, no. 3 (2009): 617-624. https://doi.org/10.3892/ijo_00000373